FindTrial
Sign In

Metaverse In Pregnant Women With Subclinical Hypothyroidism: A Prospective Randomised Study

Clinical trial of a new medical diagnosis and treatment model for pregnant women with subclinical hypothyroidism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076803
Enrollment
Unknown
Registered
2023-10-18
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subclinical hypothyroidism in pregnancy

Interventions

Metaverse Group:Metaverse platform
Traditional clinic group :Traditional clinic

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: ? According to the Guidelines for Prevention and Management of Thyroid Diseases During Pregnancy and Perinatal Period, the eligible participants were pregnant women with SCH, namely an elevated serum TSH level, higher than the upper limit of pregnancy reference (or 4.0mU/L), with normal FT4 level. ?Monocyesis. ?18-40 years old.

Exclusion criteria

Exclusion criteria: ?A history of thyroid disease. ?Autoimmune disease. ?Cardiovascular diseases, hepatic diseases, renal diseases.

Design outcomes

Primary

MeasureTime frame
The maternal and offspring’s adverse outcomes;—

Secondary

MeasureTime frame
Self-rating Anxiety Scale (SAS) ;Self-rating Depression Scale (SDS);—

Countries

China

Contacts

Public ContactZheng Yuanyuan

Fujian Provincial Hospital

175690701@qq.com+86 159 6010 7198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026